Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bicycle Therapeutics Plc ADR (BCYC)

Bicycle Therapeutics Plc ADR (BCYC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,096,632
  • Shares Outstanding, K 25,509
  • Annual Sales, $ 10,390 K
  • Annual Income, $ -51,010 K
  • 60-Month Beta -0.34
  • Price/Sales 106.80
  • Price/Cash Flow N/A
  • Price/Book 6.78
Trade BCYC with:

Options Overview Details

View History
  • Implied Volatility 131.84%
  • Historical Volatility 53.61%
  • IV Percentile 91%
  • IV Rank 98.09%
  • IV High 133.11% on 09/23/21
  • IV Low 67.05% on 08/16/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.64
  • Number of Estimates 5
  • High Estimate -0.55
  • Low Estimate -0.76
  • Prior Year -0.52
  • Growth Rate Est. (year over year) -23.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.01 +29.08%
on 08/30/21
45.21 -5.75%
on 09/16/21
+9.37 (+28.19%)
since 08/27/21
3-Month
27.05 +57.52%
on 08/20/21
45.21 -5.75%
on 09/16/21
+11.57 (+37.27%)
since 06/25/21
52-Week
17.68 +141.01%
on 11/02/20
45.21 -5.75%
on 09/16/21
+23.60 (+124.15%)
since 09/25/20

Most Recent Stories

More News
Ionis (IONS) Q2 Earnings & Revenues Fall Short of Estimates

Ionis (IONS) incurs wider-than-expected Q2 loss. The company maintains its sales guidance for 2021 but expects to incur more losses.

NVS : 82.59 (-0.41%)
BIIB : 286.62 (-1.74%)
IONS : 35.87 (-0.91%)
BCYC : 42.61 (-0.88%)
Alkermes (ALKS) Beats on Q2 Earnings & Sales, Ups '21 View

Following a positive recovery from COVID-impacts, Alkermes (ALKS) beat both earnings and sales estimates in second-quarter 2021. The company also raised its guidance for 2021.

MRK : 73.36 (-0.34%)
ALKS : 32.08 (unch)
ARVN : 87.18 (-1.61%)
BCYC : 42.61 (-0.88%)
Repligen (RGEN) Beats on Q2 Earnings & Sales, Ups 2021 View

Repligen (RGEN) reports encouraging second-quarter results, with sales and earnings beating estimates. The company also raises its guidance for 2021. Resultantly, the stock rises.

BMRN : 78.62 (+0.03%)
RGEN : 307.37 (-4.92%)
ARVN : 87.18 (-1.61%)
BCYC : 42.61 (-0.88%)
Chart of the Day: Bicycle Therapeutics Keeps Cranking

The Barchart Chart of the Day belongs to the biomedical company Bicycle Therapeutics (NASDAQ: BCYC ). Readers are always asking me how to find stocks that are just beginning to trend before everyone...

BCYC : 42.61 (-0.88%)
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Is a Great Choice for "Trend" Investors, Here's Why

Bicycle Therapeutics PLC Sponsored ADR (BCYC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks...

BCYC : 42.61 (-0.88%)
Athenex (ATNX) Skin Treatment Klisyri Gets Approval in Europe

Athenex (ATNX) announces approval for its skin treatment drug, Klisyri, in Europe. The company's partner Almirall is set to handle the launch of the drug in the region.

CDXS : 24.95 (-2.42%)
ATNX : 3.28 (+1.86%)
BCYC : 42.61 (-0.88%)
ARQT : 23.21 (+0.13%)
Albireo (ALBO) Cholestasis Drug Bylvay Gets European Approval

Albireo's (ALBO) Bylvay becomes the first and only drug to treat progressive familial intrahepatic cholestasis, following its approval in Europe.

CDXS : 24.95 (-2.42%)
ALBO : 31.95 (+1.85%)
BCYC : 42.61 (-0.88%)
ARQT : 23.21 (+0.13%)
Ionis (IONS) Inks Deal With Bicycle Therapeutics for LICA Drugs

Ionis (IONS) signs a deal with Bicycle Therapeutics to incorporate the latter's optimized Bicycle peptides into its LICA delivery platform.

AZN : 58.72 (-2.70%)
BIIB : 286.62 (-1.74%)
IONS : 35.87 (-0.91%)
BCYC : 42.61 (-0.88%)
Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that it has entered into an exclusive licensing agreement with Bicycle Therapeutics plc (NASDAQ: BCYC) to increase the delivery...

IONS : 35.87 (-0.91%)
BCYC : 42.61 (-0.88%)
Here's What Could Help Bicycle Therapeutics PLC Sponsored ADR (BCYC) Maintain Its Recent Price Strength

Bicycle Therapeutics PLC Sponsored ADR (BCYC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks...

BCYC : 42.61 (-0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.

See More

Key Turning Points

3rd Resistance Point 46.38
2nd Resistance Point 45.50
1st Resistance Point 44.06
Last Price 42.61
1st Support Level 41.74
2nd Support Level 40.86
3rd Support Level 39.42

See More

52-Week High 45.21
Last Price 42.61
Fibonacci 61.8% 34.69
Fibonacci 50% 31.44
Fibonacci 38.2% 28.20
52-Week Low 17.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar